APACT: A Phase III Trial of Nab-Paclitaxel (nab-P) Plus Gemcitabine (Gem) Versus Gem Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (PC)

Authors :: Teresa Macarulla
Margaret A. Tempero
Eileen M. O'Reilly
Hanno Riess
Malcolm A.S. Moore
Dana Backlund Cardin
Andrew V. Biankin
Xinyu Wei
Brian Lu
Lotus Yung
Philip A. Philip
David Goldstein
Source :: American Journal of Gastroenterology. 109:S72
Publication Year :: 2014
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2014.

Subjects :: Oncology
medicine.medical_specialty
Hepatology
business.industry
Gastroenterology
medicine.disease
Gemcitabine
Internal medicine
Pancreatic cancer
medicine
Adjuvant therapy
business
Nab-paclitaxel
medicine.drug

Full Text Access

Tools